Quent Capital LLC Sells 138 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Quent Capital LLC cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 16.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 686 shares of the company’s stock after selling 138 shares during the period. Quent Capital LLC’s holdings in HCA Healthcare were worth $220,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Stokes Family Office LLC boosted its position in HCA Healthcare by 2.5% during the second quarter. Stokes Family Office LLC now owns 2,049 shares of the company’s stock valued at $658,000 after purchasing an additional 49 shares during the last quarter. DNB Asset Management AS lifted its position in shares of HCA Healthcare by 47.7% in the second quarter. DNB Asset Management AS now owns 84,217 shares of the company’s stock valued at $27,057,000 after buying an additional 27,200 shares during the last quarter. Marcum Wealth LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at approximately $200,000. Massmutual Trust Co. FSB ADV lifted its position in shares of HCA Healthcare by 40.5% in the second quarter. Massmutual Trust Co. FSB ADV now owns 392 shares of the company’s stock valued at $126,000 after buying an additional 113 shares during the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of HCA Healthcare by 18.8% in the second quarter. GAMMA Investing LLC now owns 1,290 shares of the company’s stock valued at $414,000 after buying an additional 204 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jeffrey E. Cohen sold 1,650 shares of HCA Healthcare stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $313.00, for a total transaction of $516,450.00. Following the transaction, the senior vice president now directly owns 5,185 shares of the company’s stock, valued at approximately $1,622,905. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Michael S. Cuffe sold 6,311 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the completion of the sale, the executive vice president now directly owns 29,624 shares of the company’s stock, valued at approximately $9,387,253.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jeffrey E. Cohen sold 1,650 shares of the business’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $313.00, for a total value of $516,450.00. Following the completion of the sale, the senior vice president now directly owns 5,185 shares of the company’s stock, valued at $1,622,905. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,668 shares of company stock valued at $6,309,885. 1.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Barclays raised their price objective on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Royal Bank of Canada increased their target price on HCA Healthcare from $329.00 to $378.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. TD Cowen lowered their target price on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a research note on Tuesday, April 30th. Robert W. Baird started coverage on HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft increased their target price on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. Four analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $344.06.

HCA Healthcare Price Performance

Shares of HCA traded up $2.75 during midday trading on Tuesday, hitting $352.93. The company’s stock had a trading volume of 1,123,000 shares, compared to its average volume of 1,166,252. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $369.41. The company’s fifty day simple moving average is $334.83 and its two-hundred day simple moving average is $325.15. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The stock has a market capitalization of $92.44 billion, a price-to-earnings ratio of 17.80, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same quarter last year, the business posted $4.29 EPS. HCA Healthcare’s revenue for the quarter was up 10.3% on a year-over-year basis. As a group, equities analysts expect that HCA Healthcare, Inc. will post 22.43 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.75%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is presently 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.